AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/107

Authors: SZYMANSKI S LIEBERMAN J POLLACK S KANE JM SAFFERMAN A MUNNE R UMBRICHT D WOERNER M MASIAR S KRONIG M
Citation: S. Szymanski et al., GENDER DIFFERENCES IN NEUROLEPTIC NONRESPONSIVE CLOZAPINE-TREATED SCHIZOPHRENICS, Biological psychiatry, 39(4), 1996, pp. 249-254

Authors: POLLACK S
Citation: S. Pollack, DETOURS ON THE ROAD TO AUTONOMY - A CRITIQUE OF THE NEW-YORK-STATE DO-NOT-RESUSCITATE LAW, Archives of internal medicine, 156(13), 1996, pp. 1369-1371

Authors: SARAVAY SM POLLACK S STEINBERG MD WEINSCHEL B HABERT M
Citation: Sm. Saravay et al., 4-YEAR FOLLOW-UP OF THE INFLUENCE OF PSYCHOLOGICAL COMORBIDITY ON MEDICAL REHOSPITALIZATION, The American journal of psychiatry, 153(3), 1996, pp. 397-403

Authors: POLLACK S
Citation: S. Pollack, NEAR END-OF-LIFE CARE PREFERENCES, The American journal of medicine, 101(6), 1996, pp. 663-663

Authors: KLEIN E LINN S COLIN V LANG R POLLACK S LENOX RH
Citation: E. Klein et al., ANXIETY DISORDERS AMONG PATIENTS IN A GENERAL EMERGENCY SERVICE IN ISRAEL, Psychiatric services, 46(5), 1995, pp. 488-492

Authors: UMBRICHT D NOVAK G BILDER R JAVITT D POLLACK S LIEBERMAN J KANE J
Citation: D. Umbricht et al., MISMATCH NEGATIVITY, NEUROPSYCHOLOGICAL DEFICITS AND PSYCHOPATHOLOGY IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 15(1-2), 1995, pp. 187-188

Authors: STRICHMANALMASHANU L WELTFRIEND S GIDEONI O FRIEDMANBIRNBAUM R POLLACK S
Citation: L. Strichmanalmashanu et al., NO SIGNIFICANT ASSOCIATION BETWEEN HLA ANTIGENS AND CLASSIC KAPOSI-SARCOMA - MOLECULAR ANALYSIS OF 49 JEWISH PATIENTS, Journal of clinical immunology, 15(4), 1995, pp. 205-209

Authors: SHAHAR E KRIBOY N POLLACK S
Citation: E. Shahar et al., WHITE CELL ENHANCEMENT IN THE TREATMENT OF SEVERE CANDIDOSIS, Lancet, 346(8980), 1995, pp. 974-975

Authors: POLLACK S LIEBERMAN JA FLEISCHHACKER WW BORENSTEIN M SAFFERMAN AZ HUMMER M KURZ M
Citation: S. Pollack et al., A COMPARISON OF EUROPEAN AND AMERICAN DOSING REGIMENS OF SCHIZOPHRENIC-PATIENTS ON CLOZAPINE - EFFICACY AND SIDE-EFFECTS, Psychopharmacology bulletin, 31(2), 1995, pp. 315-320

Authors: SOLOMON SP WEINSCHEL B HILTON E POLLACK S SOLOMON N GROLNICK E HOFFMAN L
Citation: Sp. Solomon et al., PSYCHOLOGICAL-FACTORS HELP PREDICT COURSE OF CHRONIC LYME-DISEASE, Psychosomatics, 36(2), 1995, pp. 185-185

Authors: POHFITZPATRICK M HUANG J ZAIDER E WANG X ROTH P GARCIA O POLLACK S PIOMELLI S
Citation: M. Pohfitzpatrick et al., CONGENITAL ERYTHROPOIETIC PORPHYRIA - BIOCHEMICAL, ENZYMATIC, AND MOLECULAR-GENETIC CHARACTERISTICS OF A SEVERE PHENOTYPE, Journal of investigative dermatology, 104(4), 1995, pp. 602-602

Authors: SZYMANSKI S LIEBERMAN J POLLACK S SAFFERMAN A MUNNE R UMBRICHT D KANE J KRONIG M CHAKOS M COOPER T
Citation: S. Szymanski et al., CLOZAPINE EFFECTS ON NEUROENDOCRINE RESPONSE TO APOMORPHINE CHALLENGETESTING IN CHRONIC NEUROLEPTIC NONRESPONSIVE SCHIZOPHRENIA - PRELIMINARY FINDINGS, Biological psychiatry, 37(1), 1995, pp. 52-55

Authors: KRONIG MH MUNNE RA SZYMANSKI S SAFFERMAN AZ POLLACK S COOPER T KANE JM LIEBERMAN JA
Citation: Mh. Kronig et al., PLASMA CLOZAPINE LEVELS AND CLINICAL-RESPONSE FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS, The American journal of psychiatry, 152(2), 1995, pp. 179-182

Authors: UMBRICHT D DEGREEF G BARR WB LIEBERMAN JA POLLACK S SCHAUL N
Citation: D. Umbricht et al., POSTICTAL AND CHRONIC PSYCHOSES IN PATIENTS WITH TEMPORAL-LOBE EPILEPSY, The American journal of psychiatry, 152(2), 1995, pp. 224-231

Authors: POLLACK S BENPORATH E FUAD B RAZ R ETZIONI A
Citation: S. Pollack et al., EPIDEMIOLOGIC AND SEROLOGICAL STUDIES IN HIV-INFECTED ETHIOPIAN IMMIGRANTS TO ISRAEL, Acta paediatrica, 83, 1994, pp. 19-21

Authors: ETZIONI A POLLACK S BENISHAI Z
Citation: A. Etzioni et al., PREVENTION PROGRAM OF HIV-INFECTION IN ETHIOPIAN NEW IMMIGRANTS TO ISRAEL, Acta paediatrica, 83, 1994, pp. 22-24

Authors: ROY A POLLACK S
Citation: A. Roy et S. Pollack, ARE CEREBROSPINAL-FLUID OR URINARY MONOAMINE METABOLITE MEASURES STRONGER CORRELATES OF SUICIDAL-BEHAVIOR IN DEPRESSION, Neuropsychobiology, 29(4), 1994, pp. 164-167

Authors: MARTIN LD POLLACK S PREER JR POLISKY B
Citation: Ld. Martin et al., DNA-SEQUENCE REQUIREMENTS FOR THE REGULATION OF IMMOBILIZATION ANTIGEN-A EXPRESSION IN PARAMECIUM-TETRAURELIA, Developmental genetics, 15(5), 1994, pp. 443-451

Authors: BILDER RM WU HW CHAKOS MH BOGERTS B POLLACK S ARONOWITZ J ASHTARI M DEGREEF G KANE JM LIEBERMAN JA
Citation: Rm. Bilder et al., CEREBRAL MORPHOMETRY AND CLOZAPINE TREATMENT IN SCHIZOPHRENIA, The Journal of clinical psychiatry, 55(9), 1994, pp. 53-56

Authors: KANE JM SAFFERMAN AZ POLLACK S JOHNS C SZYMANSKI S KRONIG M LIEBERMAN JA
Citation: Jm. Kane et al., CLOZAPINE, NEGATIVE SYMPTOMS, AND EXTRAPYRAMIDAL SIDE-EFFECTS, The Journal of clinical psychiatry, 55(9), 1994, pp. 74-77

Authors: FLEISCHHACKER WW HUMMER M KURZ M KURZTHALER I LIEBERMAN JA POLLACK S SAFFERMAN AZ KANE JM
Citation: Ww. Fleischhacker et al., CLOZAPINE DOSE IN THE UNITED-STATES AND EUROPE - IMPLICATIONS FOR THERAPEUTIC AND ADVERSE-EFFECTS, The Journal of clinical psychiatry, 55(9), 1994, pp. 78-81

Authors: SAFFERMAN AZ KANE JM ARONOWITZ JS GORDON MF POLLACK S LIEBERMAN JA
Citation: Az. Safferman et al., THE USE OF CLOZAPINE IN NEUROLOGIC DISORDERS, The Journal of clinical psychiatry, 55(9), 1994, pp. 98-101

Authors: LIEBERMAN JA KANE JM SAFFERMAN AZ POLLACK S HOWARD A SZYMANSKI S MASIAR SJ KRONIG MH COOPER T NOVACENKO H
Citation: Ja. Lieberman et al., PREDICTORS OF RESPONSE TO CLOZAPINE, The Journal of clinical psychiatry, 55(9), 1994, pp. 126-128

Authors: UMBRICHT DSG POLLACK S KANE JM
Citation: Dsg. Umbricht et al., CLOZAPINE AND WEIGHT-GAIN, The Journal of clinical psychiatry, 55(9), 1994, pp. 157-160

Authors: POLLACK S BRUCE P BORENSTEIN M LIEBERMAN J
Citation: S. Pollack et al., THE RESAMPLING METHOD OF STATISTICAL-ANALYSIS, Psychopharmacology bulletin, 30(2), 1994, pp. 227-234
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>